A panelist discusses how a prospective study demonstrated that twice-daily use of a nasal spray significantly improved tear ...

Future Market Insights (FMI) has unveiled a compelling new report forecasting significant expansion in the global fuchs endothelial corneal dystrophy market. The report highlights a surge in market ...

Aim To evaluate the use of Fourier-domain optical coherence tomography (FD-OCT) in the selection and planning of surgical procedures to treat GCD2 (granular corneal dystrophy type 2). Methods An RTVue ...

“I was born with a rare disease called granular corneal dystrophy. And it’s in both eyes. And I knew that eventually I’d be losing my eyesight.

Fuchs’ Corneal Dystrophy Symptoms If you have this condition, you were born with it, but you probably won’t have symptoms until your 30s or 40s. For most people, problems don’t appear until ...

In 1910, Professor Ernst Fuchs, an Austrian ophthalmologist, published an article describing 13 patients with Fuchs’ dystrophy, a condition in the cornea that subsequently bears his name.

Granular corneal dystrophy is the slow forming of deposits in the middle layer of the cornea, which can lead to vision impairment and discomfort. Symptoms include decreased vision and eye discomfort ...

The market for Fuchs endothelial corneal dystrophy is expected to boost in the coming years. This growth can be attributed to the introduction of upcoming therapies and the rising prevalence of ...

Now, Dr. Chamberlain and other investigators are studying two new ways of replacing damaged corneal tissue in clinical trials. The first uses a technique called DSO, or Descemet’s stripping only. Used ...

A study employed CRISPR-Cas9 and a 100-nucleotide donor template to correct the R124H mutation in primary corneal keratocytes from a granular corneal dystrophy type 2 (GCD2) patient, demonstrating ...